UBS AM
HIMS icon

UBS AM’s Hims & Hers Health HIMS Stock Holding History

UBS AM’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8M Sell
425,977
-17,550
-4% -$471K ﹤0.01% 1063
2026
Q1 		$9.21M Buy
443,527
+62
+0% +$1.47K ﹤0.01% 1225
2025
Q4 		$14.4M Sell
443,465
-4,290
-1% -$184K ﹤0.01% 985
2025
Q3 		$25.4M Sell
447,755
-267,824
-37% -$13.7M 0.01% 753
2025
Q2 		$35.7M Buy
715,579
+296,880
+71% +$13.4M 0.01% 810
2025
Q1 		$12.4M Buy
418,699
+78,543
+23% +$2.92M ﹤0.01% 1140
2024
Q4 		$8.22M Buy
340,156
+81,495
+32% +$2.02M ﹤0.01% 1346
2024
Q3 		$4.76M Sell
258,661
-28,276
-10% -$506K ﹤0.01% 1597
2024
Q2 		$5.79M Buy
286,937
+111,563
+64% +$1.86M ﹤0.01% 1407
2024
Q1 		$2.71M Sell
175,374
-577
-0.3% -$6.5K ﹤0.01% 1530
2023
Q4 		$1.57M Sell
175,951
-589
-0.3% -$4.35K ﹤0.01% 1797
2023
Q3 		$1.11M Sell
176,540
-7,240
-4% -$53.8K ﹤0.01% 1904
2023
Q2 		$1.82M Hold
183,780
– – ﹤0.01% 1704
2023
Q1 		$1.82M Buy
183,780
+24,701
+16% +$216K ﹤0.01% 1704
2022
Q4 		$1.02M Buy
159,079
+53,081
+50% +$302K ﹤0.01% 1850
2022
Q3 		$591K Sell
105,998
-29,108
-22% -$175K ﹤0.01% 2268
2022
Q2 		$612K Buy
135,106
+24,796
+22% +$106K ﹤0.01% 2223
2022
Q1 		$588K Hold
110,310
– – ﹤0.01% 2400
2021
Q4 		$723K Buy
110,310
+56,890
+106% +$411K ﹤0.01% 2378
2021
Q3 		$403K Buy
53,420
+4,159
+8% +$35.2K ﹤0.01% 2563
2021
Q2 		$536K Buy
+49,261
New +$586K ﹤0.01% 2512

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS AM's HIMS Position: Q2 2026 in Review

UBS AM reduced its Hims & Hers Health (HIMS) stake by 4% in Q2 2026, selling an estimated $471K and leaving 425,977 shares worth $14.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1063.

UBS AM first reported a position in HIMS in Q2 2021 and has held it in 21 quarters since. The position peaked at $35.7M in Q2 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • UBS AM held 425,977 shares of Hims & Hers Health worth $14.8M as of Q2 2026.
  • UBS AM sold 17,550 Hims & Hers Health shares in Q2 2026, an estimated $471K.
  • Hims & Hers Health made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1063 holding.
  • UBS AM first reported a position in Hims & Hers Health in Q2 2021 and has held it in 21 quarters since.
  • UBS AM's Hims & Hers Health position peaked at $35.7M in Q2 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.